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Abstract 
 
The limitations of autogenic, allogenic and xenogenic grafting methods have led to the development 
of synthetic grafts as an alternative. The aim of this study was to manufacture highly porous and 
well interconnected hydroxyapatite scaffolds and modify them with a poly(lactic-co-glycolic acid) 
(PLGA)-bioactive glass composite coating to achieve mechanical properties close to those of 
natural cancellous bones. In this study, hydroxyapatite scaffolds were prepared from a calcium 
phosphate cement (CPC) powder and cell culture using fibroblast cells was done to examine the 
cytotoxicity of the materials used for the scaffolds. The average pore size of the scaffolds was found 
to be 650μm and the total porosity was about 80%. The hydroxyapatite scaffolds without the 
coating had a mean compressive strength and a mean compressive modulus of 0.74 MPa and 20.46 
MPa, respectively, which were in contrast to those of the scaffolds coated with the PLGA-bioacitve 
glass composite material (1.36 MPa and 24.58 MPa, respectively). The fibroblast cells were 
observed to proliferate well on the PLGA-bioactive glass coated scaffolds. The cells had also 
penetrated into the scaffold to a depth of approximately 2mm. Thus the scaffolds fabricated in this 
study exhibited a favourable porous structure and good cell response which are desirable for bone 
tissue engineering. 
 
 
1.  Introduction 
 
Current treatment techniques for bone fracture and diseases involve the use of natural bone grafts, 
of which there are three types. Autografts involve harvesting bone tissue from the patient’s own 
body, while allografts are harvested from a donor of the same species, and xenografts are from an 
animal donor. Limitations exist for each of these techniques. Harvesting autogenic bone tissue is 
mainly restricted by the morbidity of the donor site, and by the amount of healthy bone tissue 
available. Allograft and xenograft techniques, on the other hand, are limited by the suitability of 
donors, susceptibility to infection and disease, and the long term use of anti-rejection medication [1, 
2]. 
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The drawbacks of these biological grafting methods have led researchers to develop an alternative 
grafting method. This is the use of synthetic materials as temporary or permanent bone substitutes 
in the grafting process [3-5]. Over the last thirty years, many synthetic bone graft substitutes have 
emerged into the market, and about 10 percent of orthopaedic procedures performed globally today 
utilise grafts made of synthetic materials [6]. The use of such synthetic grafts in therapies for bone 
defects and bone related diseases is gaining popularity, as the synthesized materials are readily 
available and do not possess the heath risks associated with the biological grafts. 
 
Pioneer researchers in the field have stipulated that a synthetic bone graft, or bone scaffold should 
be a three dimensional structure that can be implanted into the patient as a substitute for a large 
bone defect [7-10]. Many researchers have noted that a synthetic bone graft could never satisfy all 
the characteristics of an ideal bone graft. However, biomaterials used for the fabrication of a 
synthetic scaffold should aim to be biocompatible, osteoinductive, osteoconductive, and have a 
mechanical strength similar to that of the native bone tissue [7, 10-12]. The structural properties of a 
synthetic bone graft, such as porosity and pore size were found to significantly contribute to the 
success of scaffolds [4, 13, 14]. 
 
Although a vast range of biomaterials, grouped broadly as bioactive ceramics and biodegradable 
polymers, have been considered for the construction of bone scaffolds, to date few have 
demonstrated satisfactory clinical results [15]. In light of the shortcomings of previous synthetic 
scaffolds, the aims of this study were fourfold. Firstly, to prepare porous hydroxyapatite scaffolds 
using a combined method involving polyurethane foams and hydrogen peroxide as a foaming agent. 
Secondly, to homogenously coat the hydroxyapatite scaffolds with a poly(lactic-co-glycolic acid) 
(PLGA)-bioactive glass composite material. Thirdly, to characterise the porous structure and the 
mechanical properties of the hydroxyapatite scaffolds with and without the composite coating.  
Lastly, to perform cell culture on the scaffolds to investigate the effect of porous structure on cell 
attachment and proliferation. 
 
 
2.  Expremental Procedures 
 
2.1 Preparation of Scaffolds 
 
2.1.1  Polyurethane (PU) foam preparation 
A large piece of PU foam was cut into small pieces of about 40mm x 20mm x 15mm. The cut foam 
pieces with a pore size of 1 mm were rinsed for 10 minutes three times with a sodium hydroxide 
solution, distilled water and an ethanol solution. The cut foams were then left to dry at room 
temperature.  
 
2.1.2 Preparation of porous calcium phosphate cement scaffolds  
Calcium phosphate cement (CPC) powder was prepared previously [16] at room temperature by 
mixing tetracalcium phosphate (Ca4(PO4)2O) powder and dicalcium phosphate anhydrous 
(CaHPO4) powder. The tetracalcium phosphate was prepared by firing the mixture of pyro-calcium 
phosphate (Ca2P2O7) and calcium carbonate (CaCO3) at 1350ºC for 5 hours, followed by quenching 
in air. A liquid phase consisting of a 1.0M Na2HPO4 aqueous solution and a 20 volume% H2O2 
solution was prepared in a volume ratio of 1:1. The calcium phosphate cement (CPC) powder was 
then mixed with the liquid phase in the weight ratio of 2.6g: 1.0g, to yield a homogenous paste. 
About 0.5ml of 25% ammonium salt of polymethacrylic acid solution (Darvan C, R. T. Vanderbilt) 
as a dispersant was added to the thick paste to reduce the viscosity of the mixture. The prepared PU 
foam pieces were dipped into the thin paste (or slurry), and gently squeezed several times to allow 
the slurry to penetrate the foams thoroughly. The slurry-soaked foams were then placed in an oven 
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set at 80oC for about half an hour. The temperature encouraged oxygen gas to evolve from H2O2, 
pushing the excess slurry out of the foams. When the foaming of H2O2 was near completion, and 
while the soaked foams were still damp, a sharp knife blade was used to scrape off the excess slurry 
surrounding the original PU foams. The resultant foams were left to complete the setting reactions 
between the CPC powder and the Na2HPO4 solution, leading to the formation of hydroxyapatite 
precipitates with in the PU foams.   
 
2.1.3 Preparation of sintered porous hydroxyapatite scaffolds  
The set CPC scaffolds with the embedded PU foams were fired in an electric furnace (Modutemp 
Furnace) using a four stage schedule, including (1) heating from the room temperature to 600oC at a 
rate of 1oC/minute to burn out the PU foams; (2) raising temperature from 600oC to 1200oC at a rate 
of 5oC/minute; (3) holding the temperature at 1200oC for 4 hrs to sinter the hydroxyapatite 
precipitates; (4) cooling the furnace down to room temperature at a rate of 5oC/minute. 
 
2.1.4 Modifying the sintered scaffolds with a PLGA-bioactive glass coating  
The bioactive glass (58% -SiO2-38% CaO-4%-P2O5) powder was previously prepaved by a sol-gel 
method [16]. The PLGA raw material (105K1644) was purchased from Sigma-Aldrich, Inc. The 
PLGA-bioactive glass composite material for the coating was prepared by first weighing out the 
PLGA pellets and the bioactive glass powder. The materials were used in a weight ratio of 1:1. The 
PLGA pellets were first dissolved in dichloromethane (CH2Cl2) as a solvent in a way that every 4g 
of PLGA was dissolved in 10ml of dichloromethane. On the other hand, the bioactive glass powder 
was mixed with dichloromethane, such that each 25ml of dichloromethane was added to every 5g of 
bioactive glass.  The dissolved PLGA and the dispersed bioactive glass were blended to form a 
homogenous suspension. The sintered hydroxyapatite scaffolds were then immersed into the 
suspension for about 30s each to allow for complete infiltration. The soaked scaffolds were then 
wrapped in aluminium foils and placed in a centrifuge (Phoenix, Orbital 400 Clements) to run at 
2000rpm for 30s. The scaffolds were then taken out and left to dry in a fume hood for 2 days. The 
individual scaffolds were weighed and kept in a desiccator for later use. 
 
2.2 Sample Characterization 
 
2.2.1 Porosity of the Scaffolds  
The porosity of 10 randomly picked sintered hydroxyapatite (HA) scaffolds was determined by 
using the following equations: bulk density (ρB, g/cm3) = weight of the sample/volume of the 
sample; theoretical density of HA (ρ0) = 3.16g/cm2 [17]; relative density (R.D.) = (ρB / ρ0) x 100%; 
and total porosity = 100% - R.D. The dimensions of each sample were measured using a vernier 
calliper, and the weights of the samples were measured on an electronic balance.  
 
2.2.2 Porous Structure Observation 
The porous structure of the scaffolds was inspected using a scanning electron microscope. For the 
structural observation, the scaffolds were sectioned along the sagittal and the transverse planes to 
give the best overview of the porous structure to confirm that the pores were well-connected and 
homogenously distributed throughout the entire sample. The samples used for the observation 
included the HA scaffolds with and without the PLGA-bioactive glass coating, as well as a 
commercial HA scaffold, made by a gelcasting and foaming method. 
 
2.2.3 Compressive Testing 
The compressive strengths of the various scaffolds were measured using a Hounsfield testing 
machine (Model: H10K/M527). Before placing the scaffolds on the testing machine, the scaffolds 
were trimmed to approximately 20mm x 20mm x 15mm using a Buehler Isomet low speed saw. 
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Rubber pads were placed on the top and the bottom surfaces of each sample to ensure an evenly 
distributed load on the sample. The loading speed was set at 0.5mm/min.  
 
2.3 Cell Culture Evaluation   
 
2.3.1 Sample Sterilization 
The in-house fabricated and the commercial scaffolds were cut into 10mm x 6mm x 6mm pieces, to 
fit into the wells of the cell culture plate. To decontaminate the scaffolds prior to use in the cell 
culture experiments, the scaffolds were soaked three times in a 70% ethanol solution for 15 minutes 
each, and rinsed with a phosphate buffer solution (PBS), and left to dry overnight in a sterilized 
hood. The sterilized scaffolds were then sealed in cell culture wells and kept in a fridge at 4oC for 
later use. 
 
2.3.2 Cell Seeding and Cell Culture 
Human foreskin fibroblast cells, HFF1 P36, were removed from a cell culture flask by carefully 
pouring away the medium in the flask, and washing the remaining contents with 10ml of PBS. Then 
2ml of trypsin EDTA was added into the flask and was placed in an incubator at 37oC for 2 minutes. 
Once the cells started to slide off the growth surface of the flask, 5ml of culture medium 
(Dulbecco’s Modified Eagle Medium + 10% FCS + 1% P&S) was added. After centrifugation and 
removing the supernatant, the cells were diluted with the fresh culture medium to obtain a cell 
density of 104cells/20μl. Then 20μl of the cell mixture was pipetted onto each sample. The samples 
were then left at rest for about 1 minute before the culture medium was added slowly from the wall 
of the well to immerse the sample. The cell-seeded scaffolds were placed in an incubater (37oC, 5% 
CO2) for 14 days, and the culture medium in each well was changed every 4 days.  
 
2.3.3 Cell Observation Using Scanning Electron Microscopy 
The medium in each well was pipetted out, and immediately replaced with PBS. The rinsing with 
PBS was repeated three times for each sample, and after the last rinsing, the scaffolds were fixed 
with 3% glutaraldehyde. The scaffolds were then processed by soaking in an osmium tetroxide 
solution for an hour, dehydrated through graded concentrations of ethanol solutions, and treated 
with 100% amyl acetate two times for 15 minutes each. The scaffolds were then dried using critical 
point drying before being fixed onto the aluminium stubs with a carbon tape. Lastly, the scaffolds 
were coated with gold in a gold sputter coater. 
 
 
3. Results and Discussion 
 
3.1.  Porous Structure 
The sintered HA scaffolds fabricated in this study displayed a highly porous and well 
interconnected open pore structure. The pore size varied in the range of 400µm to 900µm, with an 
average of 650µm (Fig. 1). The total porousity of the scaffolds ranged between 70% and 80%. The 
observed final porous structure was controlled by the initial PU foam porous structure and by the 
foaming process of the H2O2 as the foaming agent. When the hydrogen peroxide decomposed into 
water and oxygen gas, the released oxygen gas created bubbles, thus pushing out the excess slurry 
away from the PU foam and ceating a porosity.  However, the frameworks of the PU foam were 
able to limit the sizes of the gas bubbles formed, thus controlling the pore size of the final HA 
scaffold.  
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Fig. 1  Scanning electron micrographs of a polyurethane foam (A) and a hydroxyapaptite scaffold 
(B) fabricated using the combined PU foam-foaming method and sintering. 
 
The porous structure within the struts of the HA scaffold was also examined. Micropores (mostly 
open) were found and the grains of the sintered HA were also revealed. The strut surface 
morphology of the HA scaffold appeared rough and grainy (Fig. 2 A). The HA phase of the study 
was confirmed in the previous study [16]. The porous struts of the scaffolds were able to be 
reinforced  by the PLGA polymer through the PLGA infiltration and coating process. However, 
pure PLGA coating may affect the bioactivity of the parent HA scaffolds, thus, bioactive glass 
particles were added in the PLGA matrix for the coating purpose. The surface morphology of the 
scaffold coated with the PLGA-bioactive glass composite (Fig. 2 B) looked much smoother 
compared to the uncoated HA scaffold.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig.2  Scanning electron micrographs showing the surface morphology of a hydroxyapatite strut (A)  
and a PLGA-bioactive glass coated hydroxyaptite strut (B). 
20 μmA 20 μm B
2.0 mm B2.0 mmA 
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3.2 Compressive strength  
 
Compressive tests were conducted on the HA scaffolds and the HA scaffolds coated with the 
PLGA-bioactive glass composite. Fig. 3 shows the stress-strain behaviour of the scaffolds. The 
curves of the HA scaffolds displayed a rather sharp break off point compared to the coated 
scaffolds. This is a distinct characteristic of a brittle material. The curves of the PLGA-bioactive 
glass coated HA scaffolds, on the other hand, displayed a characteristic less of a brittle material and 
more of a plastic material. The compressive strength and the compressive modulus of the scaffolds 
coated with the PLGA-bioactive glass were observed to be greater than those of bare HA scaffolds, 
although the difference between the values was small. The small difference in the compressive 
strength and the compressive modulus was due to the applied thin layer of the composite coating. 
 
The compressive strength and the compressive modulus found in this experiment were comparable 
to those of cancellous bones. It is therefore believed that if implanted, these scaffolds would not 
cause the problem of stress-shielding, which occurs when an implant is stiffer than the surrounding 
tissues. However, the strength of the scaffolds could be improved with a thicker layer of composite 
material coating 
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Fig. 3  Stress-strain curves of the hydroxyapatite scaffolds (A) and the PLGA-bioactive glass coated 
hydroxyaptite scaffolds (B). Samples 1, 2, and 3 are three identical specimens for the testing. 
 
 
 
3.3  Cell Growth 
 
The fibroblast cells after 14 days of culture were found to be growing to semi-confluence on the 
PLGA-bioactive glass coated scaffolds. The densely populated cells appeared to be growing in 
multiple layers (Fig. 4), creating a strong sheet of cells, and were observed to cover pores less than 
500µm in diameter. The cells were also observed to attach well on the walls of the scaffolds, and 
closely followed the contours. 
 
The cells shown on the PLGA-bioactive glass coated scaffold were observed to have penetrated 
about 2mm into the scaffold (Fig. 5). As the cells migrated into the scaffold, they were less densely 
packed compared to those near the surface. Cells in the colony (A) attached themselves closely to 
the walls of the scaffold, while the colony (B) displayed a slightly different behaviour, i.e., the cells 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
0 0.05 0.1 0.15 0.2 0.25
Strain
St
re
ss
 (M
Pa
)
Sample 1
Sample 2
Sample 3
B 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
0 0.05 0.1 0.15 0.2 0.25 0.3
Strain
St
re
ss
 (M
Pa
)
Sample 1
Sample 2
Sample 3
A 
 8
not only lined the walls of the tunnels in the porous structure, but also stretched themselves out 
across the diameter of the tunnel. 
 
From the results gathered for the cell culture, it was concluded that the HA scaffolds coated with 
PLGA-bioactive glass composite were safe materials to use as they promoted good cell attachment 
and allowed cell proliferation. Although cells on both the HA scaffolds and the PLGA-bioactive 
glass coated HA scaffolds were proliferating well, the chance of the cells to cover up the pores and 
block up the tunnels that were less than 500µm in diameter was high. This type of cell behaviour is 
of concern for both in vitro and in vivo situations; if the cells block the porous channels around and 
within the scaffold, the cells will affect the invasion of vascular networks, and restrict the transport 
of nutrients and gases. The combination of these effects could cause a build up of metabolic waste, 
cell necrosis and an inflammatory response when implanted into a patient.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4 SEM micrographs of the surface areas A and B showing cell growth in the PLGA-bioactive 
glass coated HA scaffold. 
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Fig. 5  SEM micrographs of a cross-section of the PLGA-bioactive glass coated HA scaffold with 
cells lining closely on the pore wall of the scaffold (A) and cells filling up the open pore by 
stretching themselves across the pore (B). 
 
 
3.4 Cell Growth on a Commercial Scaffold 
 
A similar cell culture was performed on a commercial scaffold made of hydroxyapaptite. From Fig. 
6, it can be seen that the fibroblast cells proliferated well on the top surface. The cells were 
spreading across the pores, substantially reducing the opening of the pores. It can also be seen that 
the pores in the scaffolds were observed to be spherical and were of various sizes from 200µm to 
600µm. The pores were connected by small windows, i.e., the contact regions between pores. The 
sizes of the windows varied from 20µm to 150µm. It can be said that it was the smaller window size 
that restricted the penetration of the cells.  
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B
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Fig. 6  SEM micrographs of the top surface (A) and a cross-section (B) of the commercial scaffold 
after 14 days of cell culture. 
 
 
4.  Conclusions 
 
The results from this study have led to the following conclusions: 
 
1. The pore size (~650 μm) and the pore interconnectivity of the fabricated hydroxyapatite scaffolds 
closely mimicked those of the initial polyurethane foams used. 
2. The compressive strength (1.36 MPa) and the compressive modulus (24.58 MPa) of the HA 
scaffolds modified with the PLGA-bioactive glass coating were remarkably 
higher that those of the bare HA scaffolds (0.74 MPa and 20.46 MPa, respectively).  
3. The human foreskin fibroblast cells were observed to grow on and penetrate into (depth of 2 mm) 
the PLGA-bioactive glass coated scaffolds after the cells were seeded and cultured for 14 days, 
which was superior to the commercial scaffold in terms of cell ingrowth. The difference of cell 
ingrowth into the scaffolds seemed to be controlled by the smallest pore sizes of the scafflolds.  
 
While cell culture with fibroblasts was done to evaluate the biological perfomance of the scafoflds, 
in future studies, osteoblast cells should be used as they are more relevant to bone regeneration. In 
vivo bone ingrowth of the scaffolds will also be studied.  
 
 
Acknowledgement 
 
The project was partially supported by the IHBI Rsearch Seeding Grant 2006. 
 
 
References 
 
[1] American Dental Association: Journal of the American Dental Association 133(8) (2002), p. 
1125. 
[2] D. Powers, A. Torosian and J. Turowski: http://www.pages.drexel.edu/~djp27/page3.html. 
2 mm 
Cells 
B
2 mm 
A
 11
[3] R.-S. Spitzer, C. Perka, K. Lindenhayn and H. Zippel: Journal of Biomedical Materials 
Research 59(4) (2002), p. 690. 
[4] A.J. Salgado, O.P. Coutinho and R.L. Reis: Macromolecular Bioscience 4(8) (2004), p. 743. 
[5] M.J. Yaszemski, J.B. Oldham, L.Lu and B.L.Currier, in: Bone Engineering, 1st Edition, 
1994, Toronto: Em squared Inc. 
[6] Medcompare: https://www.medcompare.com/spotlight.asp?spotlightid=216. 
[7] S.-S. Kim, M.S. Park, O. Jeon, C.Y. Choi and B.-S. Kim: Biomaterials 27(8) (2006), p. 
1399. 
[8] C.T. Laurencin, M. Attawia and M.D. Borden: Current Opinion in Orthopedics 10(6) 
(1999), p. 445. 
[9] A.G.A. Coombes and M.C. Meikle: Clinical Materials 17(1) (1994), p. 35. 
[10] S.C. Rizzi, D.J. Heath, A.G.A. Coombes, N. Bock, M. Textor and S. Downes: Journal of 
Biomedical Materials Research 55(4) (2001), p. 475. 
[11] A.C. Stähelin, A. Weiler, H. Rüfenacht, R. Hoffmann, A. Geissmann and R. Feinstein:  
Arthroscopy: The Journal of Arthroscopic & Related Surgery 13(2) (1997), p. 238. 
[12] C.T. Laurencin and Y. Khan: http://www.emedicine.com/orthoped/topic611.htm. 
[13] K. Rezwan, Q.Z. Chen, J.J. Blaker and A.R. Boccaccini: Biomaterials 27(18) (2006), p. 
3413. 
[14] X. Miao, W.-K. Lim, X. Huang and Y. Chen: Materials Letters 59(29-30) (2005), p. 4000. 
[15] A.S. Greenwald, S.D. Boden, V.M. Goldberg, Y. Khan, C.T. Laurencin and R.N. Rosier: 
The Journal of Bone and Joint Surgery 83 (2001), p. 98. 
[16] X. Miao, L.-P. Tan, L.-S. Tan and X. Huang: Materials Science and Engineering: C 27[2] 
(2007), p. 274. 
[17] X. Huang and X. Miao: Journal of Biomaterials Applications, in press, first published online 
on March 16, 2006 as doi:10.1177/0885328206063905. 
 
